PGJQX
Price
$18.13
Change
+$0.04 (+0.22%)
Updated
Jul 25 closing price
Net Assets
48.03M
VCRVX
Price
$14.48
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Net Assets
933.13M
Interact to see
Advertisement

PGJQX vs VCRVX

Header iconPGJQX vs VCRVX Comparison
Open Charts PGJQX vs VCRVXBanner chart's image
PGIM Jennison Global Infrastructure R6
Price$18.13
Change+$0.04 (+0.22%)
VolumeN/A
Net Assets48.03M
NYLI CBRE Global Infrastructure Inv Cl
Price$14.48
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets933.13M
PGJQX vs VCRVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGJQX vs. VCRVX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGJQX is a Buy and VCRVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCRVX has more cash in the bank: 933M vs. PGJQX (48M). VCRVX pays higher dividends than PGJQX: VCRVX (1.74) vs PGJQX (1.45). PGJQX was incepted earlier than VCRVX: PGJQX (9 years) vs VCRVX (5 years). PGJQX (1.56) is less costly to investors than VCRVX (1.35). PGJQX is a more actively managed with annual turnover of: 80.00 vs. VCRVX (47.00). PGJQX has a lower initial minimum investment than VCRVX: PGJQX (0) vs VCRVX (1000). VCRVX (16.53) and PGJQX (16.39) have marching annual gain over last year. VCRVX return over 5 years is better than : 41.49 vs. PGJQX (32.93).
PGJQXVCRVXPGJQX / VCRVX
Total Expense Ratio1.171.3587%
Annual Report Gross Expense Ratio1.561.35116%
Fund Existence9 years5 years-
Gain YTD14.04312.208115%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets48M933M5%
Annual Yield % from dividends1.451.7484%
Returns for 1 year16.3916.5399%
Returns for 3 years25.7620.88123%
Returns for 5 years32.9341.4979%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV1.430.04
+2.88%
Acrivon Therapeutics
TKR81.660.90
+1.11%
Timken Company (The)
SERA3.25N/A
N/A
Sera Prognostics
VERA21.81-0.07
-0.32%
Vera Therapeutics
NOW968.79-27.39
-2.75%
SERVICENOW